secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001104659-23-069992
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharmaceuticals holds 2023 annual meeting; all director nominees elected
--------------------------------------------------------------------------------

- All seven director nominees elected with substantial votes for; highest withheld was Robert J. Wills with 1,317,985 withheld.
- PricewaterhouseCoopers LLP appointed as auditor for the Company with 23,410,435 votes for and 41,638 withheld.
- Broker non-votes ranged from 9,626,977 to 9,626,978 per director nominee.
- Meeting held virtually on June 7, 2023; proposals described in proxy statement filed April 28, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/0001104659-23-069992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/tm2318330d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-069992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer